Among the 7 trends that will disrupt the life sciences industry, generative AI has highest focus. Read our latest report for insights: infy.com/3VB6YgI The life sciences industry is on the brink of a new era of innovation. From AI-powered clinical trials to digital patient companions, every industry process and touchpoint is being reimagined or upended. Presenting - Infosys Life sciences journal! This inaugural report details the life sciences industry perspective with insights to help industry leaders. Read to understand the 7 trends that will enable leaders to harness rapid change, transform their enterprises, and deliver breakthroughs for life. #lifesciences #pharma #pharmaceutical #AI #generativeAI Subhro Mallik Vishal Goyal, Ph.D Jeff Kavanaugh Phil Benton Infosys Consultingn Infosys Anne Bichteler, Ph.D. David Champeaux Srinivas Chilukuri Marcello Di Maulo - MSc IT, EMBA Surya Duvvuri Ed Francis Marta Picon Hernandez Sudip Hui George Hunnewell Prabhat Kaul Ashish Mishra Luca Morreale Suresh Ramasubbu Ashutosh Raut Thomas Røhme Gurdeep Singh Rooprai Vivek Ruikar Ian Storr Martin Woergaard Nikki Seifert, PhD Kate Bevan Jeff Mosier Chad Watt Pragya Rai Snehal Bhosale Isaac LaBauve Pramath Kant, Ph.D. Dylan Cosper
Infosys Knowledge Institute’s Post
More Relevant Posts
-
Although AI spending in life sciences is up, the cost and complexity of implementation splits enterprises. Full report: infy.com/3VB6YgI The life sciences industry is on the brink of a new era of innovation. From AI-powered clinical trials to digital patient companions, every industry process and touchpoint is being reimagined or upended. Presenting - Infosys Life sciences journal! This inaugural report details the life sciences industry perspective with insights to help industry leaders. Read to understand the 7 trends that will enable leaders to harness rapid change, transform their enterprises, and deliver breakthroughs for life. #lifesciences #pharma #pharmaceutical #AI #generativeAI Subhro Mallik Vishal Goyal, Ph.D Jeff Kavanaugh Phil Benton Infosys Consulting Anne Bichteler, Ph.D. David Champeaux Srinivas Chilukuri Marcello Di Maulo - MSc IT, EMBA Surya Duvvuri Ed Francis Marta Picon Hernandez Sudip Hui George Hunnewell Prabhat Kaul Ashish Mishra Luca Morreale Suresh Ramasubbu Ashutosh Raut Thomas Røhme Gurdeep Singh Rooprai Vivek Ruikar Ian Storr Martin Woergaard Nikki Seifert, PhD Kate Bevan Jeff Mosier Chad Watt Pragya Rai Snehal Bhosale Isaac LaBauve Pramath Kant, Ph.D. Dylan Cosper
To view or add a comment, sign in
-
-
What is the potential of AI in pharma? Subhro Mallik, EVP Head of Life Sciences, Infosys shares his thoughts in this clip. Watch the full interview for more insights here: https://lnkd.in/ehjAqwkG #pharmaAI #patientcare #digitalhealth Pramod Pratap Infosys Life Sciences
To view or add a comment, sign in
-
Interesting insights from Infosys Knowledge Institute on where ROI from generative AI will be made in life sciences in the next 3 years.
The life sciences industry is on the brink of a new era of innovation. From AI-powered clinical trials to digital patient companions, every industry process and touchpoint is being reimagined or upended. Presenting - Infosys Life sciences journal! This inaugural report details the life sciences industry perspective with insights to help industry leaders. Read to understand the 7 trends that will enable leaders to harness rapid change, transform their enterprises, and deliver breakthroughs for life. #lifesciences #pharma #pharmaceutical #AI #generativeAI Subhro Mallik Vishal Goyal, Ph.D Jeff Kavanaugh Phil Benton Infosys Consulting Infosys Anne Bichteler, Ph.D. David Champeaux Srinivas Chilukuri Marcello Di Maulo - MSc IT, EMBA Surya Duvvuri Ed Francis Marta Picon Hernandez Sudip Hui George Hunnewell Prabhat Kaul Ashish Mishra Luca Morreale Suresh Ramasubbu Ashutosh Raut Thomas Røhme Gurdeep Singh Rooprai Vivek Ruikar Ian Storr Martin Woergaard Nikki Seifert, PhD Kate Bevan Jeff Mosier Chad Watt Pragya Rai Snehal Bhosale Isaac LaBauve Pramath Kant, Ph.D. Dylan Cosper infy.com/3VB6YgI
To view or add a comment, sign in
-
Alumni Relations & Global Marketing Strategy at BCG | Communications, Engagement, Content Creation | Spotlighting the essence of the human experience as a storyteller | Ally🏳️🌈 | Mental Health🧩 | Neurodiversity🧠
As someone who: 1) has a parent who worked at MSD during my formative years as a teenager (looking at you Rajesh MARWAHA), 2) started their career in the biopharma industry at one of the 'Merck's ( the German-based Merck Group, specifically) which inculcated an interest & deep appreciation for the often overlooked sheer hard work that goes behind bringing novel therapies to market, let alone all of the preceding R&D effort, creativity, and numerous failures for that one critical success to follow 3) has been a BCGer for the last 3 years 4) is a Gen Z'er whose life has been pervaded by and is unimaginable without GenAI anymore at the consumer level, despite it just being the commencement of this fascinating journey 5) But most importantly, as a human - who is excited and HOPEFUL to see more of the good that AI can bring to the table when it comes to the advancement of human health... I find it super exciting that Boston Consulting Group (BCG) has announced it has entered a strategic collaboration with Merck, known as MSD outside of the US and Canada. The collaboration will leverage artificial intelligence and generative artificial intelligence (AI and GenAI) to potentially enable the discovery and assessment of novel drug targets. As part of the collaboration, BCG X (the tech build and design unit of BCG) will work with Merck to develop algorithms that use AI to mine robust omics data in an effort to better understand causal relationships between biomarkers and disease biology to facilitate drug target discovery. The collaboration will initially focus on disease networks and pathways for chronic and degenerative diseases. Read more here: https://bcg.smh.re/A-J
To view or add a comment, sign in
-
-
🚀 HCL Technologies dives into innovative solutions that address critical challenges in pharma. From AI to data analytics, learn how these trends are reshaping healthcare. Read the article for valuable insights: https://hubs.ly/Q02fQnfs0 #PharmaTech #Innovation #ITManagement #ITinfrastructure #ITsupport #ITservices #ITconsulting #managedServices #Itstrategy
Breaking barriers: Navigating technology trends to mitigate pharma challenges | HCLTech
hcltech.com
To view or add a comment, sign in
-
A week ago, I had the privilege of talking about Digital Transformation at the #CDOIQ conference organized by #MIT. This topic is close to our hearts at GSK. Admittedly it’s an ambiguous realm. But at GSK, we're not just discussing change, we're driving it, converting the vast amount of data generated by our R&D each year into tangible business value. I took an example of an Atlas Product that we fully launched a year ago, sharing the principles behind our user and business-centric approach, specifically designed for Knowledge & Decision-Making. This has been a great example of the digital transformation journey we are on in R&D, meeting the urgent need to manage knowledge effectively and help our scientists make smarter decisions. But we're not stopping there. As I highlighted at the conference's conclusion, Generative AI is giving us the means to further accelerate our transformation into the digital age, capitalizing on the vast pool of R&D knowledge we continue to accumulate. At GSK, we stand at the exciting intersection of science and cutting-edge technology to deliver new medicines to patients faster. #CDOIQ #DigitalTransformation #KnowledgeManagement #DecisionMaking #GenerativeAI #GSK
To view or add a comment, sign in
-
Revvity Signals Software stands at the forefront of scientific innovation, offering a comprehensive suite of informatics solutions that anticipate and address the rapid pace of our evolving world. With a focus on proactive problem-solving, Revvity's platform caters to diverse industries, from Pharma and Biotech to Energy & Petrochemicals, empowering researchers to capture, analyze, and leverage data for groundbreaking discoveries and life-changing therapies. Driven by a legacy of excellence and a team of world-class scientists, Revvity Signals Software is renowned for its flagship applications like ChemDraw® and E-Notebook, alongside cutting-edge platforms such as Signals Research Platform and strategic partnerships like Spotfire®. Operating globally and serving over 10 million end-users, their commitment to scientific advancement is evident, making Revvity an indispensable ally for those shaping the future of research and innovation. Learn more about their unparalleled and comprehensive commitment to leveraging computational prowess in this PharmaFEATURES Interview Special with Zev Wisotsky, Ph.D., Revvity Signals' Senior Principal Marketing Director: https://lnkd.in/gQjmjKRs #proventainternational #strategymeeting #drugdiscoverybiology #drugdiscovery #bioinformatics #cheminformatics #dataanalytics #artificialintelligence #modelling #revvitysignals #revvity
Amidst the deluge of data, finding the right balance between working models and useful insights remains pivotal in forging the path toward leveraging computational success in the field of biotech and pharma. That's where Revvity Signals Software comes in! Revvity Signals Software has more than three decades of providing unrivaled support for scientific workflows. Revvity's powerful solutions are used across R&D disciplines from drug discovery to specialty chemicals material development. In this latest PharmaFEATURES Interview Special, Revvity Signals' Senior Principal Marketing Manager, Zev Wisotsky, Ph.D. sheds light on how Revvity brings scientific data analytics to visual life. https://lnkd.in/gH_856ay #bioinformatics #cheminformatics #dataanalytics #analytics #modeling #artificialintelligence #ai #drugdiscovery #computation #software #revvitysignalssoftware #revvitysignals #revvity
AI & Analytics for Next-Gen Drug Discovery Solutions with Zev Wisotsky, Revvity Signals - PharmaFeatures
pharmafeatures.com
To view or add a comment, sign in
-
Amidst the deluge of data, finding the right balance between working models and useful insights remains pivotal in forging the path toward leveraging computational success in the field of biotech and pharma. That's where Revvity Signals Software comes in! Revvity Signals Software has more than three decades of providing unrivaled support for scientific workflows. Revvity's powerful solutions are used across R&D disciplines from drug discovery to specialty chemicals material development. In this latest PharmaFEATURES Interview Special, Revvity Signals' Senior Principal Marketing Manager, Zev Wisotsky, Ph.D. sheds light on how Revvity brings scientific data analytics to visual life. https://lnkd.in/gH_856ay #bioinformatics #cheminformatics #dataanalytics #analytics #modeling #artificialintelligence #ai #drugdiscovery #computation #software #revvitysignalssoftware #revvitysignals #revvity
AI & Analytics for Next-Gen Drug Discovery Solutions with Zev Wisotsky, Revvity Signals - PharmaFeatures
pharmafeatures.com
To view or add a comment, sign in
-
Check out this interview from Zev Wisotsky around AI & Data analytics in next gen drug discovery informatics solutions
Amidst the deluge of data, finding the right balance between working models and useful insights remains pivotal in forging the path toward leveraging computational success in the field of biotech and pharma. That's where Revvity Signals Software comes in! Revvity Signals Software has more than three decades of providing unrivaled support for scientific workflows. Revvity's powerful solutions are used across R&D disciplines from drug discovery to specialty chemicals material development. In this latest PharmaFEATURES Interview Special, Revvity Signals' Senior Principal Marketing Manager, Zev Wisotsky, Ph.D. sheds light on how Revvity brings scientific data analytics to visual life. https://lnkd.in/gH_856ay #bioinformatics #cheminformatics #dataanalytics #analytics #modeling #artificialintelligence #ai #drugdiscovery #computation #software #revvitysignalssoftware #revvitysignals #revvity
AI & Analytics for Next-Gen Drug Discovery Solutions with Zev Wisotsky, Revvity Signals - PharmaFeatures
pharmafeatures.com
To view or add a comment, sign in